LAG3  ||| S:0 E:5 ||| NNP
expression  ||| S:5 E:16 ||| NN
in  ||| S:16 E:19 ||| IN
active  ||| S:19 E:26 ||| JJ
Mycobacterium  ||| S:26 E:40 ||| FW
tuberculosis  ||| S:40 E:53 ||| FW
infections  ||| S:53 E:64 ||| FW
Mycobacterium  ||| S:64 E:78 ||| FW
tuberculosis  ||| S:78 E:91 ||| FW
( ||| S:91 E:92 ||| -LRB-
MTB ||| S:92 E:95 ||| NNP
)  ||| S:95 E:97 ||| -RRB-
is  ||| S:97 E:100 ||| VBZ
a  ||| S:100 E:102 ||| DT
highly  ||| S:102 E:109 ||| RB
successful  ||| S:109 E:120 ||| JJ
pathogen  ||| S:120 E:129 ||| NN
because  ||| S:129 E:137 ||| IN
of  ||| S:137 E:140 ||| IN
its  ||| S:140 E:144 ||| PRP$
ability  ||| S:144 E:152 ||| NN
to  ||| S:152 E:155 ||| TO
persist  ||| S:155 E:163 ||| VB
in  ||| S:163 E:166 ||| IN
human  ||| S:166 E:172 ||| JJ
lungs  ||| S:172 E:178 ||| NNS
for  ||| S:178 E:182 ||| IN
long  ||| S:182 E:187 ||| JJ
periods  ||| S:187 E:195 ||| NNS
of  ||| S:195 E:198 ||| IN
time ||| S:198 E:202 ||| NN
.  ||| S:202 E:204 ||| .
MTB  ||| S:204 E:208 ||| NNP
modulates  ||| S:208 E:218 ||| VBD
several  ||| S:218 E:226 ||| JJ
aspects  ||| S:226 E:234 ||| NNS
of  ||| S:234 E:237 ||| IN
the  ||| S:237 E:241 ||| DT
host  ||| S:241 E:246 ||| NN
immune  ||| S:246 E:253 ||| JJ
response ||| S:253 E:261 ||| NN
.  ||| S:261 E:263 ||| .
Lymphocyte-activation  ||| S:263 E:285 ||| JJ
gene  ||| S:285 E:290 ||| NN
3  ||| S:290 E:292 ||| CD
( ||| S:292 E:293 ||| -LRB-
LAG3 ||| S:293 E:297 ||| NNP
)  ||| S:297 E:299 ||| -RRB-
is  ||| S:299 E:302 ||| VBZ
a  ||| S:302 E:304 ||| DT
protein  ||| S:304 E:312 ||| NN
with  ||| S:312 E:317 ||| IN
a  ||| S:317 E:319 ||| DT
high  ||| S:319 E:324 ||| JJ
affinity  ||| S:324 E:333 ||| NN
for  ||| S:333 E:337 ||| IN
the  ||| S:337 E:341 ||| DT
CD4  ||| S:341 E:345 ||| JJ
receptor  ||| S:345 E:354 ||| NN
and  ||| S:354 E:358 ||| CC
is  ||| S:358 E:361 ||| VBZ
expressed  ||| S:361 E:371 ||| VBN
mainly  ||| S:371 E:378 ||| RB
by  ||| S:378 E:381 ||| IN
regulatory  ||| S:381 E:392 ||| JJ
T  ||| S:392 E:394 ||| NN
cells  ||| S:394 E:400 ||| NNS
with  ||| S:400 E:405 ||| IN
immunomodulatory  ||| S:405 E:422 ||| JJ
functions ||| S:422 E:431 ||| NNS
.  ||| S:431 E:433 ||| .
To  ||| S:433 E:436 ||| TO
understand  ||| S:436 E:447 ||| VB
the  ||| S:447 E:451 ||| DT
function  ||| S:451 E:460 ||| NN
of  ||| S:460 E:463 ||| IN
LAG3  ||| S:463 E:468 ||| CD
during  ||| S:468 E:475 ||| IN
MTB  ||| S:475 E:479 ||| NNP
infection ||| S:479 E:488 ||| NN
,  ||| S:488 E:490 ||| ,
a  ||| S:490 E:492 ||| DT
nonhuman  ||| S:492 E:501 ||| JJ
primate  ||| S:501 E:509 ||| JJ
model  ||| S:509 E:515 ||| NN
of  ||| S:515 E:518 ||| IN
tuberculosis ||| S:518 E:530 ||| NN
,  ||| S:530 E:532 ||| ,
which  ||| S:532 E:538 ||| WDT
recapitulates  ||| S:538 E:552 ||| VBZ
key  ||| S:552 E:556 ||| JJ
aspects  ||| S:556 E:564 ||| NNS
of  ||| S:564 E:567 ||| IN
natural  ||| S:567 E:575 ||| JJ
human  ||| S:575 E:581 ||| JJ
infection  ||| S:581 E:591 ||| NN
in  ||| S:591 E:594 ||| IN
rhesus  ||| S:594 E:601 ||| JJ
macaques  ||| S:601 E:610 ||| NNS
( ||| S:610 E:611 ||| -LRB-
Macaca  ||| S:611 E:618 ||| UH
mulatta ||| S:618 E:625 ||| UH
) ||| S:625 E:626 ||| -RRB-
,  ||| S:626 E:628 ||| ,
was  ||| S:628 E:632 ||| VBD
used ||| S:632 E:636 ||| VBN
.  ||| S:636 E:638 ||| .
We  ||| S:638 E:641 ||| PRP
show  ||| S:641 E:646 ||| VBP
that  ||| S:646 E:651 ||| IN
the  ||| S:651 E:655 ||| DT
expression  ||| S:655 E:666 ||| NN
of  ||| S:666 E:669 ||| IN
LAG3  ||| S:669 E:674 ||| NNP
is  ||| S:674 E:677 ||| VBZ
highly  ||| S:677 E:684 ||| RB
induced  ||| S:684 E:692 ||| VBN
in  ||| S:692 E:695 ||| IN
the  ||| S:695 E:699 ||| DT
lungs  ||| S:699 E:705 ||| NNS
and  ||| S:705 E:709 ||| CC
particularly  ||| S:709 E:722 ||| RB
in  ||| S:722 E:725 ||| IN
the  ||| S:725 E:729 ||| DT
granulomatous  ||| S:729 E:743 ||| JJ
lesions  ||| S:743 E:751 ||| NNS
of  ||| S:751 E:754 ||| IN
macaques  ||| S:754 E:763 ||| NNS
experimentally  ||| S:763 E:778 ||| VBP
infected  ||| S:778 E:787 ||| VBN
with  ||| S:787 E:792 ||| IN
MTB ||| S:792 E:795 ||| NNP
.  ||| S:795 E:797 ||| .
Furthermore ||| S:797 E:808 ||| RB
,  ||| S:808 E:810 ||| ,
we  ||| S:810 E:813 ||| PRP
show  ||| S:813 E:818 ||| VBP
that  ||| S:818 E:823 ||| IN
LAG3  ||| S:823 E:828 ||| CD
expression  ||| S:828 E:839 ||| NN
is  ||| S:839 E:842 ||| VBZ
not  ||| S:842 E:846 ||| RB
induced  ||| S:846 E:854 ||| VBN
in  ||| S:854 E:857 ||| IN
the  ||| S:857 E:861 ||| DT
lungs  ||| S:861 E:867 ||| NNS
and  ||| S:867 E:871 ||| CC
lung  ||| S:871 E:876 ||| NN
granulomas  ||| S:876 E:887 ||| NN
of  ||| S:887 E:890 ||| IN
animals  ||| S:890 E:898 ||| FW
exhibiting  ||| S:898 E:909 ||| FW
latent  ||| S:909 E:916 ||| FW
tuberculosis  ||| S:916 E:929 ||| FW
infection ||| S:929 E:938 ||| FW
.  ||| S:938 E:940 ||| .
However ||| S:940 E:947 ||| RB
,  ||| S:947 E:949 ||| ,
simian  ||| S:949 E:956 ||| JJ
immunodeficiency  ||| S:956 E:973 ||| JJ
virus-induced  ||| S:973 E:987 ||| JJ
reactivation  ||| S:987 E:1000 ||| NN
of  ||| S:1000 E:1003 ||| IN
latent  ||| S:1003 E:1010 ||| JJ
tuberculosis  ||| S:1010 E:1023 ||| JJ
infection  ||| S:1023 E:1033 ||| NN
results  ||| S:1033 E:1041 ||| NNS
in  ||| S:1041 E:1044 ||| IN
an  ||| S:1044 E:1047 ||| DT
increased  ||| S:1047 E:1057 ||| JJ
expression  ||| S:1057 E:1068 ||| NN
of  ||| S:1068 E:1071 ||| IN
LAG3  ||| S:1071 E:1076 ||| CD
in  ||| S:1076 E:1079 ||| IN
the  ||| S:1079 E:1083 ||| DT
lungs ||| S:1083 E:1088 ||| NNS
.  ||| S:1088 E:1090 ||| .
This  ||| S:1090 E:1095 ||| DT
response  ||| S:1095 E:1104 ||| NN
is  ||| S:1104 E:1107 ||| VBZ
not  ||| S:1107 E:1111 ||| RB
observed  ||| S:1111 E:1120 ||| VBN
in  ||| S:1120 E:1123 ||| IN
nonhuman  ||| S:1123 E:1132 ||| NNS
primates  ||| S:1132 E:1141 ||| VBP
infected  ||| S:1141 E:1150 ||| VBN
with  ||| S:1150 E:1155 ||| IN
non-MTB  ||| S:1155 E:1163 ||| JJ
bacterial  ||| S:1163 E:1173 ||| JJ
pathogens ||| S:1173 E:1182 ||| NN
,  ||| S:1182 E:1184 ||| ,
nor  ||| S:1184 E:1188 ||| CC
with  ||| S:1188 E:1193 ||| IN
simian  ||| S:1193 E:1200 ||| JJ
immunodeficiency  ||| S:1200 E:1217 ||| JJ
virus  ||| S:1217 E:1223 ||| NN
alone ||| S:1223 E:1228 ||| RB
.  ||| S:1228 E:1230 ||| .
Our  ||| S:1230 E:1234 ||| PRP$
data  ||| S:1234 E:1239 ||| NNS
show  ||| S:1239 E:1244 ||| VBP
that  ||| S:1244 E:1249 ||| IN
LAG3  ||| S:1249 E:1254 ||| NNP
was  ||| S:1254 E:1258 ||| VBD
expressed  ||| S:1258 E:1268 ||| VBN
primarily  ||| S:1268 E:1278 ||| RB
on  ||| S:1278 E:1281 ||| IN
CD4 ||| S:1281 E:1284 ||| NNP
( ||| S:1284 E:1285 ||| -LRB-
+ ||| S:1285 E:1286 ||| NNP
)  ||| S:1286 E:1288 ||| -RRB-
T  ||| S:1288 E:1290 ||| NN
cells ||| S:1290 E:1295 ||| NNS
,  ||| S:1295 E:1297 ||| ,
presumably  ||| S:1297 E:1308 ||| RB
by  ||| S:1308 E:1311 ||| IN
regulatory  ||| S:1311 E:1322 ||| JJ
T  ||| S:1322 E:1324 ||| NN
cells  ||| S:1324 E:1330 ||| NNS
but  ||| S:1330 E:1334 ||| CC
also  ||| S:1334 E:1339 ||| RB
by  ||| S:1339 E:1342 ||| IN
natural  ||| S:1342 E:1350 ||| JJ
killer  ||| S:1350 E:1357 ||| NN
cells ||| S:1357 E:1362 ||| NNS
.  ||| S:1362 E:1364 ||| .
The  ||| S:1364 E:1368 ||| DT
expression  ||| S:1368 E:1379 ||| NN
of  ||| S:1379 E:1382 ||| IN
LAG3  ||| S:1382 E:1387 ||| CD
coincides  ||| S:1387 E:1397 ||| NN
with  ||| S:1397 E:1402 ||| IN
high  ||| S:1402 E:1407 ||| JJ
bacterial  ||| S:1407 E:1417 ||| JJ
burdens  ||| S:1417 E:1425 ||| NNS
and  ||| S:1425 E:1429 ||| CC
changes  ||| S:1429 E:1437 ||| NNS
in  ||| S:1437 E:1440 ||| IN
the  ||| S:1440 E:1444 ||| DT
host  ||| S:1444 E:1449 ||| NN
type  ||| S:1449 E:1454 ||| NN
1  ||| S:1454 E:1456 ||| CD
helper  ||| S:1456 E:1463 ||| CD
T-cell  ||| S:1463 E:1470 ||| JJ
response ||| S:1470 E:1478 ||| NN
.  ||| S:1478 E:1480 ||| .
